Last update 31 Dec 2024
Infectex LLC

Infectex LLC

Holding Company|
2011|
Russia
|
infectex.ru

Overview

Tags

Respiratory Diseases
Infectious Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Infectious Diseases2
Top 5 Drug TypeCount
Small molecule drug2
Top 5 TargetCount
CMV DNA terminase1
MmpL3(Mycobacterium tuberculosis mycolic acid transporter)1

Related

2
Drugs associated with Infectex LLC
SQ-109
Target
MmpL3
Mechanism
MmpL3 inhibitors
Active Org.
Infectex LLCInfectex LLC
Originator Org.
Sequella, Inc.Sequella, Inc.
Active Indication
Pulmonary Tuberculosis
Inactive Indication
Helicobacter pylori infection
Drug Highest PhasePhase 3
First Approval Ctry. / Loc.-
First Approval Date-
Telacebec
Target
CMV DNA terminase
Mechanism
CMV DNA terminase inhibitors
Active Org.
Infectex LLCInfectex LLC [+1]
Originator Org.
Qurient Co., Ltd.Qurient Co., Ltd.
Active Indication
Buruli Ulcer [+1]
Inactive Indication
COVID-19 [+1]
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Infectex LLC
Login to view more data
0 Patents (Medical) associated with Infectex LLC
Login to view more data
100 Deals associated with Infectex LLC
Login to view more data
100 Translational Medicine associated with Infectex LLC
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 01 Jan 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1
1
1
Phase 3
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
SQ-109
 ( MmpL3 )		Pulmonary Tuberculosis
More
Phase 3
Telacebec
 ( CMV DNA terminase )		Pulmonary Tuberculosis
More
Phase 1
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free